GLP-1 receptor agonists slow stomach emptying enough that standard pre-surgery fasting may not prevent dangerous aspiration of stomach contents during anesthesia.
Fasting may not be enoughGLP-1 drugs slow stomach emptying so significantly that patients may have residual food in their stomachs even after following standard pre-surgery fasting instructions
What the researchers found
GLP-1 receptor agonists slow gastric emptying as part of their mechanism of action, which creates a new challenge for anesthesiologists: patients on these drugs may have food or liquid remaining in their stomachs even after standard fasting periods before surgery. This residual gastric content increases the risk of regurgitation and pulmonary aspiration during anesthesia — a potentially life-threatening complication.
The risk is particularly elevated for patients who already have gastroparesis (delayed stomach emptying) or who are undergoing procedures without a protected airway (such as sedation without intubation). The article reviews international consensus guidelines and provides structured recommendations for perioperative risk stratification and management of patients on GLP-1 drugs.
Why it matters
With tens of millions of people now taking GLP-1 drugs for diabetes and weight loss, anesthesiologists are encountering this issue daily. Standard fasting guidelines (nothing to eat for 6-8 hours before surgery) were developed before GLP-1 drugs existed and may not be adequate for these patients. This review addresses a genuine patient safety concern and provides practical guidance for one of the most common drug-anesthesia interactions clinicians now face.
The numbers in context
GLP-1 RAs increase residual gastric content · Standard fasting may be inadequate · Multiple international guidelines reviewed · Risk stratification framework provided
How the study worked
This is a narrative review published in Anesthesiology Clinics that summarizes current evidence on GLP-1 receptor agonists' effects on gastric emptying and their implications for anesthesia and airway management. The authors reviewed various international consensus guidelines and synthesized recommendations for perioperative management, including risk stratification approaches for patients on GLP-1 drugs.
Who was studied
Review article focused on patients taking GLP-1 receptor agonists who require anesthesia or sedation
What this study cannot tell us
The evidence base for specific perioperative management of GLP-1 RA patients is still emerging, and most guidelines are based on expert consensus rather than large randomized trials. The actual incidence of aspiration events attributable to GLP-1 drugs during anesthesia is not well quantified. Recommendations may evolve as more data becomes available. The review does not specify how different GLP-1 drugs (short-acting vs. long-acting) compare in aspiration risk.
How to read the evidence
This is a clinical review in a respected anesthesiology journal that synthesizes available evidence and international guidelines. The underlying evidence base is largely observational and expert consensus-driven, as randomized trials on this specific safety question are understandably difficult to conduct.
When this study was published
Published in 2026 in Anesthesiology Clinics. This is an extremely current review addressing a rapidly evolving clinical concern as GLP-1 drug use continues to expand.
The bigger picture
This is part of a broader reckoning across medicine as GLP-1 drugs become ubiquitous. Their effects extend far beyond weight loss and blood sugar — they change fundamental body functions like gastric emptying that other medical specialties depend on. Anesthesiology is one of the first fields to formally adapt its practice guidelines to the GLP-1 era, but similar reassessments are underway in gastroenterology, emergency medicine, and radiology. As the patient population on these drugs continues to grow, perioperative safety protocols must evolve to keep up.
Questions still open
- Should patients be specifically instructed to hold their GLP-1 drug before surgery, and if so, how many days in advance?
- Would routine point-of-care gastric ultrasound before anesthesia induction become standard of care for patients on GLP-1 drugs?
- Is the aspiration risk meaningfully different between weekly injectables (semaglutide) and daily oral formulations (oral semaglutide)?
Common questions
Should I stop my GLP-1 medication before surgery?
What happens if your stomach isn't empty during anesthesia?
Read the original research
Airway Management in the Age of GLP-1 Receptor Agonists: New Challenges and Solutions.
Anesthesiology clinics, 44(1), 125-137
Citation
Valkeniers, Karolien; Wallyn, An; Van de Putte, Peter; Hogg, Rosemary M G. (2026). Airway Management in the Age of GLP-1 Receptor Agonists: New Challenges and Solutions.. Anesthesiology clinics, 44(1), 125-137. https://doi.org/10.1016/j.anclin.2025.10.010